Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CSIRO Maintains Key Patent for shRNA Gene Silencing Technology After European Opposition 2015-11-17 16:00
Derek Muhs to Attend UBS Disruptive Technology CEO Summit in Hong Kong, November 16, 2015 2015-11-16 23:00
China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2016 Financial Results 2015-11-16 19:00
Bionomics and MSD Hosting Cognition and Alzheimer's Symposium Featuring Australian and US Speakers 2015-11-13 19:00
Darling Ingredients Inc. Reports Third Quarter 2015 Financial Results: Sequential Adjusted EBITDA Growth, Continued Debt Reduction 2015-11-13 05:35
VolitionRx to Present at Two Conferences in November 2015-11-12 20:00
Genesis Healthcare expands its Consumer Testing to Asia starting November 17th, 2015 2015-11-12 13:00
AliveCor and ILLIES Announce New Distribution Agreement in Hong Kong and Macau 2015-11-12 09:00
Novogen Patent Covering Cantrixil and Trilexium Accepted in Australia 2015-11-12 08:04
Sinovac Reports Unaudited Third Quarter Financial Results 2015-11-12 07:00
ISS and Glass Lewis Recommend that WuXi PharmaTech Shareholders Vote "FOR" the Proposed Going-Private Transaction 2015-11-12 01:01
Jacoti Named as CES 2016 Innovation Awards Honoree for Tech for a Better World 2015-11-11 20:00
"Technologies from Science Park" Programme Accelerates Adoption of Home-grown Technological Innovations by Leading Business Entities 2015-11-11 17:59
Russian Citizens to use Futronic FS64 Fingerprint Scanner to apply for Schengen Visa at PONY EXPRESS 2015-11-11 16:00
Preclinical Studies Justify Mode of Delivery and Dosing Regimen for Anisina 2015-11-11 06:40
WuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in China 2015-11-11 05:30
Breakthrough Prize To Award $22 Million In Science Prizes 2015-11-09 14:09
Samsung Bioepis' SB4 and SB2 Investigational Biosimilar Candidates Sustain Comparable Safety Profiles in One-Year Phase 3 Clinical Studies 2015-11-09 10:27
Samsung Bioepis' SB4 and SB2 Investigational Biosimilar Candidates Sustain Comparable Safety Profiles in One-Year Phase 3 Clinical Studies 2015-11-08 09:46
PTS Diagnostics' Patent Enforcement Against Jant Pharmacal Gains Momentum 2015-11-07 01:23
1 386 387 388 389 390 452